Reviews and feature articleAsthma and the elite athlete: Summary of the International Olympic Committee's Consensus Conference, Lausanne, Switzerland, January 22-24, 2008
Section snippets
Does the athlete have asthma?
Asthma is a syndrome with many clinical phenotypes.4 Exercise-induced asthma is the occurrence of a transient narrowing of the airways after exercise that is reversible by inhalation of a β2-agonist in an individual with asthma. When narrowing of the airways occurs only with exercise, this phenomenon is best described as EIB.5 The term EIB is self-explanatory and is used throughout this article.
Sports activities at an elite level are often associated with symptoms that may be suggestive of
Optimal management of asthma in athletes
The goal of asthma treatment is to reduce or prevent respiratory symptoms and to optimize pulmonary function.40 Management of asthma in athletes should be similar to management in nonathletes, with attention to patient education (which is often deficient in athletes),41 reduction of relevant environmental exposures, treatment of associated comorbid conditions, individualized pharmacotherapy, prevention of exacerbations, and regular follow-up (Fig 1). Athletes should also be advised to avoid
β2-Agonists experience at Olympic Games
In 2004, requiring Olympic athletes to demonstrate evidence of asthma or AHR to inhale β2-agonists resulted in a 27% reduction in their use from the 2000 Olympics, when notification only was accepted.2 Identified in 2001, the markedly skewed prevalence of β2-agonist notifications was confirmed after use of β2-agonists had to be approved in 2002. A higher percentage of β2-agonist notifications/approved applications was observed in summer sports with a major endurance component in competition
Environmental aspects of asthma in elite athletes
Airway function can be affected by exposure to seasonal and perennial allergens in sensitized individuals, dry/cold air, and poor quality air containing pollutants such as chlorine derivatives in swimming pools, ozone and oxides of nitrogen, and fine and ultrafine PM derived from combustion.69 The effects may be greater in subjects with asthma than without asthma. Because of the high minute ventilation during exercise, the effects of these exposures may be more marked in athletes than in
Training as a cause of asthma
The prevalences of asthma, EIB, and AHR are increased in elite athletes.6, 47, 83 For swimmers, this has been attributed to the frequent recommendation for patients with asthma to engage in this sport. However, the proportion of elite swimmers who commence swimming because of asthma compared with those who develop asthma and/or AHR after years of intense training is unknown. Several studies in the last decade have suggested that long-term intense endurance training may promote the development
Why are patients with asthma successful at the Olympic Games?
Athletes who notified β2-agonist use in Sydney and were approved to inhale β2-agonists in Salt Lake City, Athens, and Torino won more individual Olympic medals than their counterparts without asthma at each Games (see this article's Fig E3 in the Online Repository at www.jacionline.org).
The differences were greater in winter athletes than in summer athletes because a greater percentage of winter competitions can be classed as endurance events. Of the 28 summer sports, 6—boxing, wrestling,
References (92)
- et al.
Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics
J Allergy Clin Immunol
(2006) - et al.
The mechanism of exercise-induced asthma is…
J Allergy Clin Immunol
(2000) - et al.
Prevalence of respiratory symptoms in an athlete population
Respir Med
(2003) - et al.
Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma
Chest
(2003) - et al.
Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma
J Allergy Clin Immunol
(2006) - et al.
Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast
Ann Allergy Asthma Immunol
(2006) - et al.
A comparison of two challenge tests for identifying exercise-induced bronchospasm in figure skaters
Chest
(1999) - et al.
Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes
Chest
(2004) - et al.
Exercise in elite summer athletes: challenges for diagnosis
J Allergy Clin Immunol
(2002) - et al.
Hyperosmolarity as the stimulus to asthma induced by hyperventilation?
J Allergy Clin Immunol
(1986)
Sensitivity and specificity of histamine PC20 determination in a random selection of young college students
J Allergy Clin Immunol
Leukotrienes in the pathogenesis of asthma
Chest
Humidity influences exercise capacity in subjects with exercise-induced bronchoconstriction (EIB)
Respir Med
Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol
Respir Med
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge
Respir Med
Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol
Chest
A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol
J Allergy Clin Immunol
Non-invasive evaluation of lower airway inflammation in hyper-responsive elite cross-country skiers and asthmatics
Respir Med
Residential proximity fine particles related to allergic sensitisation and asthma in primary school children
Respir Med
Effect of continuing or finishing high-level sports on airway inflammation, bronchial hyperresponsiveness, and asthma: a 5-year prospective follow-up study of 42 highly trained swimmers
J Allergy Clin Immunol
Responses to bronchial challenge submitted for approval to use inhaled beta2 agonists prior to an event at the 2002 Winter Olympics
J Allergy Clin Immunol
b2-Agonists at the Olympic Games
Clin Rev Allergy Immunol
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986
Am Rev Respir Dis
Asthma and wheezing among Norwegian elite athletes
Med Sci Sports Exerc
Asthma medication in Finnish Olympic athletes: no signs of inhaled beta2-agonist overuse
Med Sci Sports Exerc
Differences in the evaluation and management of exercise-induced bronchospasm between family physicians and pulmonologists
J Asthma
Self-reported symptoms and exercise-induced asthma in the elite athlete
Med Sci Sports Exerc
Impact of changes in the IOC-MC asthma criteria: a British perspective
Thorax
ERS Task Force. Indirect airway challenges
Eur Respir J
Guidelines for methacholine and exercise challenge testing - 1999
Am J Respir Crit Care Med
Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction
Br J Sports Med
The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline
Respir Res
Dose-response over time to inhaled fluticasone propionate: treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma
Pediatr Pulmonol
Single dose agents in the prevention of exercise-induced asthma: a descriptive review
Treat Respir Med
Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise
Br J Sports Med
Exercise-induced asthma screening of elite athletes: field vs laboratory exercise challenge
Med Sci Sports Exerc
Sensitivity to heat and water loss at rest and during exercise in asthmatic patients
Eur J Respir Dis
Eucapnic voluntary hyperventilation of compressed gas mixture: a simple system for bronchial challenge by respiratory heat loss
Am Rev Respir Dis
Inhaled mannitol: a screening test to identify potential exercise-induced bronchoconstriction in elite athletes
Med Sci Sports Exerc
Guidelines for standardization of bronchial challenge with (nonspecific) bronchoconstricting agents. Working Group on Bronchial Hyperreactivity SEPCR
Bull Eur Physiopathol Respir
Rapid method for measurement of bronchial responsiveness
Thorax
Airway responses to eucapnic hyperpnea, exercise and methacholine in elite swimmers
Med Sci Sports Exerc
Respiratory symptoms and prevalence of airway hyperresponsiveness (AHR) in elite swimmers
Am J Respir Crit Care Med
Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects
Thorax
Exercise-induced bronchoconstriction: pathogenesis
Curr Allergy Asthma Rep
Criteria for diagnosis of asthma, exercise-induced bronchoconstriction and airway hyperresponsiveness for athlete: lessons from the Olympic Games
Eur Respir Mon
Cited by (194)
Respiratory medicine as part of athlete and team care
2023, The Youth Athlete: A Practitioner's Guide to Providing Comprehensive Sports Medicine CareSwimming
2023, The Youth Athlete: A Practitioner's Guide to Providing Comprehensive Sports Medicine CareAsthma
2022, Allergy EssentialsThe role of cardiopulmonary exercise testing in evaluating children with exercise induced dyspnoea
2021, Paediatric Respiratory ReviewsWork Group Report: Perspectives in Diagnosis and Management of Exercise-Induced Bronchoconstriction in Athletes
2020, Journal of Allergy and Clinical Immunology: In PracticeBronchial Provocation Testing for the Identification of Exercise-Induced Bronchoconstriction
2020, Journal of Allergy and Clinical Immunology: In Practice
Consensus Conference supported by the International Olympic Committee.
Disclosure of potential conflict of interest: K. D. Fitch is a member of the International Olympic Committee (IOC) Medical Commission and chair of the IOC Independent Asthma Panel. M. Sue-Chu is on the Advisory Board of Novartis and GlaxoSmithKline, has delivered lectures funded by AstraZeneca, has participated in a clinical trial funded by Novartis, and is a member of the IOC Independent Asthma Panel. S. D. Anderson invented the mannitol test for Pharmaxis Ltd and is a member of the IOC Independent Asthma Panel. L.-P. Boulet has received sponsorship or funding from AstraZeneca, GlaxoSmithKline, Merck Frosst, Schering-Plough, Novartis, Alexion, AsthmaTx, Boehringer-Ingelheim, Ception, Genentech, IVAX, MedImmune, Topigen, and Wyeth. D. C. McKenzie has received research funding from the World Anti-Doping Agency and is a member of the IOC Independent Asthma Panel. V. Backer has received research funding from Pharmaxis Ltd and the Danish Lung Association and is a member of the Advisory Board of MSD, Novartis, ALK-Abelló, AstraZeneca, and GlaxoSmithKline. K. W. Rundell has delivered lectures sponsored by Merck and has received research funding from the World Anti-Doping Agency, Pharmaxis, SkyPharma, and Forest Research. P. Kippelen has received research funding from the British Olympic Association and is a member of the IOC Independent Asthma Panel. The rest of the authors have declared that they have no conflict of interest.